BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years.
Robertson L; Hanson H; Seal S; Warren-Perry M; Hughes D; Howell I; Turnbull C; Houlston R; Shanley S; Butler S; Evans DG; Ross G; Eccles D; Tutt A; Rahman N; British Journal Of Cancer, 2012, vol. 106, issue 6, p 1234, ISSN 15321827. ISBN 15321827.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef